UK regulator identifies 30 cases of blood clot events after AstraZeneca jab

The United States may not need AstraZeneca’s vaccine, even if it wins US regulatory approval, Anthony Fauci, the nation’s top infectious disease doctor told Reuters.

The vaccine, once hailed as another milestone in the fight against the COovid-19 pandemic, has been dogged by questions since late last year, even as it has been authorised for use by dozens of countries, not including the US.

Dr Fauci, director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to the White House, said the US has enough contracts with other vaccine makers to vaccinate its entire population, and possibly enough for booster shots in the fall.

Dr Fauci said: “If you look at the numbers (of doses) that we’re going to be getting, the amount that you can get from J&J, from Novavax from Moderna if we contract for more, it is likely that we can handle any boost that we need, but I can’t say definitely for sure.”